Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$65.20 USD
-0.74 (-1.12%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $65.12 -0.08 (-0.12%) 7:10 PM ET
4-Sell of 5 4
B Value C Growth D Momentum C VGM
Brokerage Reports
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 241 - 260 ( 521 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Countdown to EASL Begins: Presentation Titles Released
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Immuno-Oncology Key Opinion Leader Conference Call Recap
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R